WS
CNCR

Wedbush Securities’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Wedbush Securities’s Portfolio CNCR Stock Details CNCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,661
Closed -$202K – 1184
2021
Q3 		$202K Sell
6,661
-556
-8% -$16.9K 0.01% 1067
2021
Q2 		$230K Sell
7,217
-822
-10% -$26.2K 0.01% 994
2021
Q1 		$241K Buy
8,039
+1,616
+25% +$48.4K 0.01% 910
2020
Q4 		$204K Buy
+6,423
New +$204K 0.02% 780